rss
05-30-2015, 03:01 PM
Global Glaucoma Therapeutics market will grow at a CAGR of 2.53% During 2015
Glaucoma Therapeutics Market 2015 to 2019 (http://www.marketresearchstore.com/report/global-glaucoma-therapeutics-market-2014-2018-10773) – Industry Size, Share, Trends and Forecasts by Global Solar News
Glaucoma is a disease of the eye in which fluid pressure within the eye increases. If left untreated the patient may lose vision and even become blind. The exact etiology of optic nerve damage due to glaucoma is **t fully k**wn, but involves mechanical compression and/or decreased blood flow in the optic nerve. Based on whether the cause of the disease is unk**wn or k**wn, glaucoma is divided into two types, open angle and closed angle glaucoma. Five main classes of medical treatment are currently used to lower intraocular pressure: prostaglandins, beta blockers, alpha adrenergic agonists, carbonic anhydrase inhibitors, and fixed dose combinations.
Global Glaucoma Therapeutics market will grow at a CAGR of 2.53 percent over the period 2013-2018. (http://www.marketresearchstore.com/report/global-glaucoma-therapeutics-market-2014-2018-10773#reportTableOfContent)
Covered in this Report
The Global Glaucoma Therapeutics market can be divided into five segments: Prostaglandins, Beta Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, and Fixed Dose Combinations. To calculate the market size, the report considers the revenue generated from the sales of various ophthalmic solutions used in the treatment of glaucoma.
Global Glaucoma Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Glaucoma Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Request For Sample Report Here: http://www.marketresearchstore.com/report/global-glaucoma-therapeutics-market-2014-2018-10773#requestSample
Key Regions
– Americas
– EMEA
– APAC
Key Vendors
– Allergan Inc.
– Merck & Co. Inc.
– **vartis AG
– Pfizer Inc.
Other Prominent Vendors
– Acadia Pharmaceuticals Inc.
– AC Immune SA
– Acorn Biomedical Inc.
– Advanced Cell Tech**logy Inc.
– Aerie Pharmaceuticals Inc.
– Carl Zeiss Meditec Inc.
– Falcon Pharmaceuticals Ltd.
– I**tek Pharmaceuticals Corp.
– Lexicon Pharmaceuticals Inc.
– Neurotech Pharmaceuticals Inc.
– NicOx SA
– Otsuka Holdings Co. Ltd.
– Phytopharm plc
– Santen Pharmaceuticals Co. Ltd.
– Senju Pharmaceutical Co. Ltd.
– SIFI SpA
– Valeant Pharmaceuticals International Inc.
Key Market Drivers
– Increasing Prevalence of Eye Disorders.
– For a full, detailed list, view our report.
Key Market Challenges
– Increasing Number of Patent Expirations.
– For a full, detailed list, view our report.
Key Market Trends
– Increase in Awareness of Glaucoma.
– For a full, detailed list, view our report.
The post Global Glaucoma Therapeutics market will grow at a CAGR of 2.53% During 2015 (http://www.medgadget.com/2015/05/global-glaucoma-therapeutics-market-will-grow-cagr-2-53-2015.html) appeared first on Medgadget (http://www.medgadget.com).
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=RHz1lKA_0IE:XI4QZcfc3Dc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=RHz1lKA_0IE:XI4QZcfc3Dc:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=RHz1lKA_0IE:XI4QZcfc3Dc:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=RHz1lKA_0IE:XI4QZcfc3Dc:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/RHz1lKA_0IE
Glaucoma Therapeutics Market 2015 to 2019 (http://www.marketresearchstore.com/report/global-glaucoma-therapeutics-market-2014-2018-10773) – Industry Size, Share, Trends and Forecasts by Global Solar News
Glaucoma is a disease of the eye in which fluid pressure within the eye increases. If left untreated the patient may lose vision and even become blind. The exact etiology of optic nerve damage due to glaucoma is **t fully k**wn, but involves mechanical compression and/or decreased blood flow in the optic nerve. Based on whether the cause of the disease is unk**wn or k**wn, glaucoma is divided into two types, open angle and closed angle glaucoma. Five main classes of medical treatment are currently used to lower intraocular pressure: prostaglandins, beta blockers, alpha adrenergic agonists, carbonic anhydrase inhibitors, and fixed dose combinations.
Global Glaucoma Therapeutics market will grow at a CAGR of 2.53 percent over the period 2013-2018. (http://www.marketresearchstore.com/report/global-glaucoma-therapeutics-market-2014-2018-10773#reportTableOfContent)
Covered in this Report
The Global Glaucoma Therapeutics market can be divided into five segments: Prostaglandins, Beta Blockers, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, and Fixed Dose Combinations. To calculate the market size, the report considers the revenue generated from the sales of various ophthalmic solutions used in the treatment of glaucoma.
Global Glaucoma Therapeutics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Glaucoma Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Request For Sample Report Here: http://www.marketresearchstore.com/report/global-glaucoma-therapeutics-market-2014-2018-10773#requestSample
Key Regions
– Americas
– EMEA
– APAC
Key Vendors
– Allergan Inc.
– Merck & Co. Inc.
– **vartis AG
– Pfizer Inc.
Other Prominent Vendors
– Acadia Pharmaceuticals Inc.
– AC Immune SA
– Acorn Biomedical Inc.
– Advanced Cell Tech**logy Inc.
– Aerie Pharmaceuticals Inc.
– Carl Zeiss Meditec Inc.
– Falcon Pharmaceuticals Ltd.
– I**tek Pharmaceuticals Corp.
– Lexicon Pharmaceuticals Inc.
– Neurotech Pharmaceuticals Inc.
– NicOx SA
– Otsuka Holdings Co. Ltd.
– Phytopharm plc
– Santen Pharmaceuticals Co. Ltd.
– Senju Pharmaceutical Co. Ltd.
– SIFI SpA
– Valeant Pharmaceuticals International Inc.
Key Market Drivers
– Increasing Prevalence of Eye Disorders.
– For a full, detailed list, view our report.
Key Market Challenges
– Increasing Number of Patent Expirations.
– For a full, detailed list, view our report.
Key Market Trends
– Increase in Awareness of Glaucoma.
– For a full, detailed list, view our report.
The post Global Glaucoma Therapeutics market will grow at a CAGR of 2.53% During 2015 (http://www.medgadget.com/2015/05/global-glaucoma-therapeutics-market-will-grow-cagr-2-53-2015.html) appeared first on Medgadget (http://www.medgadget.com).
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=RHz1lKA_0IE:XI4QZcfc3Dc:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=RHz1lKA_0IE:XI4QZcfc3Dc:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=RHz1lKA_0IE:XI4QZcfc3Dc:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=RHz1lKA_0IE:XI4QZcfc3Dc:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/RHz1lKA_0IE